Strain Catalog

Showing results 6401 to 6500 of 7208

< Previous 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 Next >
Strain Descriptor Strain Summary Genotype Phenotype
[act15]:dimB:GFPAX4 cells expressing dimB-GFP under the control of the constitutive act15 promoteraxeA1, axeB1, axeC1, dimB:GFPl, neoR
[act15]:dkhCdhkC overexpressed in KAX3 axeA1, axeB1, axeC1, dhkC, [pHK12neo], neoR
[act15]:dng1dng1 under the control of the act15 promoter axeA2, axeB2, axeC2, [act15]:dng1, neoR
[act15]:dnmA:mycC-terminal myc-tagged DNA methyltransferaseaxeA2, axeB2, axeC2, [dnmA-C-myc], neoR, bsRaxe,neoR,wt
[act15]:drkC(1-497):YFPC-terminal YFP fusion to drkC where the kinase domain has been deleted expressed in wild typeaxeA2, axeB2, axeC2, drkC(1-497)-YFP, [pYU20], neoR
[act15]:dymA:GFPdymA-GFP expressed in AX2 cellsaxeA2, axeB2, axeC2, dymA:GFP, neoR
[act15]:dymB:YFPdymB tagged with YFP overexpressed in AX2axeA2, axeB2, axeC2, dymB:YFP, neoR
[act15]:eif2s1(S53A)eif2s1 with an serine/alanine substitution at residue 53 expressed in AX4 cellsaxeA1, axeB1, axeC1, eif2s1(S53A), [pBsr], bsr
[act15]:eif2s1(S53A)/[bzpR]:lacZlacZ under control of the bzpR promotor expressed in eif2s1 cells with an serine/alanine substitution at residue 53axeA1, axeB1, axeC1, eif2s1(S53A), [pBsr], lacZ, [pbzpR-9], bsr, neoR
[act15]:eIF6eIF6 overexpressed in AX2axeA2, axeB2, axeC2, eIF6, [pDXA-3C], neoR
[act15]:empC:GFPGFP-empC fusion at the c-terminusaxeA2, axeB2, axeC2, [pDEX27]empC:GFP, neoR
[act15]:enlA(92-497)expression of a truncated enlA (enlazin; residues 92-497) in wild type AX3:REP orf+ cells , acting as a dominant-negativeaxeA1, axeB1, axeC1, [pREP], enlA(92-497), [pLD1A15SN], neoR
[act15]:fbxA:FLAGfbxA FLAG-tagged at the C terminus under the control of the act15 promoter in AX2axeA2, axeB2, axeC2, [act15]:fbxA:FLAG, neoR
[act15]:fip(1163-2038)C-terminal portion of fip expressed in AX4 cellsaxeA1, axeB1, axeC1, fip(1163-2038), [pDEX], neoR
[act15]:FLAG:cycCN-terminal FLAG-tagged CycC overexpressed in AX2 cells under control of the act15 promotoraxeA2, axeB2, axeC2, [act15:FLAG:cycC], neoR
[act15]:FLAG:hbx4FLAG-tagged hbx4 overexpressed in KAX3 cellsaxeA1, axeB1, axeC1, FLAG:hbx4, [pTX-FLAG], neoR
[act15]:FLAG:hbx4/[act15]:cadAmutant overexpressing FLAG-tagged hbx4 and rescued by overexpressing cadAaxeA1, axeB1, axeC1, FLAG:hbx4, [pTX-FLAG], cadA, [pEXP4(+)], bsR, neoR
[act15]:FLAG:hbx4/[ecmAO]:lacZhxb4 overexpressor expressing lacZ under the control of the prestalk ecmAO promoteraxeA1, axeB1, axeC1, FLAG:hbx4, [pTX-FLAG], [ecmAO]:lacZ, neoR
[act15]:FLAG:mybBFLAG-tagged mybB under control of act15 promotor expressed in AX2axeA2, axeB2, axeC2, FLAG:mybB, [pTX-FLAG], neoR
[act15]:FLAG:ppp4CFLAG-tagged ppp4C overexpressed in wild typeaxeA1, axeB1, axeC1, FLAG: ppp4C, [pEXP4(+)], neoR
[act15]:FLAG:ppp4C(H113Q)FLAG-tagged ppp4C that contains a H113Q mutation that disrupts phosphatase activity, overexpressed in wild typeaxeA1, axeB1, axeC1, FLAG: ppp4C(H113Q), [pEXP4(+)], neoR
[act15]:FLAG:Rab14(Q67L)constitutively active rab14 in NCA4 cellsaxe, FLAG:Rab14(Q67L), neoR
[act15]:FLAG:racE(T25N/E180R/S192D)constitutively GDP-bound, phospho-mimetic, FLAG-tagged racE(T25N/E180R/S192D) expressed in AX2axeA2, axeB2, axeC2, racE(T25N/E180R/S192D), [pTX-GFP], neoR
[act15]:FLAG:rasC(Q62L)constitutively active rasC(Q62L) in AX2axeA2, axeB2, axeC2, rasC(Q62L), pTX-GFP, neoR
[act15]:FLAG:rasC(Q62L/E157R/R164E)constitutively active rasC(Q62L/E157R/R164E) in AX2axeA2, axeB2, axeC2, rasC(Q62L/E157R/R164E), neoR
[act15]:FLAG:sir2AFLAG-tagged sir2A under control of act15 promotor expressed in AX2axeA2, axeB2, axeC2, FLAG:sir2A, [pTX-FLAG], neoR
[act15]:FLAG:sir2CFLAG-tagged sir2C under control of act15 promotor expressed in AX2axeA2, axeB2, axeC2, FLAG:sir2C, [pTX-FLAG], neoR
[act15]:FLAG:sir2DFLAG-tagged sir2D under control of act15 promotor expressed in AX2axeA2, axeB2, axeC2, FLAG:sir2D, [pTX-FLAG], neoR
[act15]:FLAG:wdr45l(A196D)N-terminal FLAG-tagged wdr45l with A196D substitution in AX4axeA1, axeB1, axeC1, wdr45l(A196D), [pDM320], neoR
[act15]:FLAG:wdr45l(G192D)N-terminal FLAG-tagged wdr45l with G192D substitution in AX4axeA1, axeB1, axeC1, wdr45l(G192D), [pDM320], neoR
[act15]:FLAG:wdr45l(T197P)N-terminal FLAG-tagged wdr45l with T197P substitution in AX4axeA1, axeB1, axeC1, wdr45l(T197P), [pDM320], neoR
[act15]:fpsoverexpression of fps under the control of the actin 15 promoter; blasticidin resistantaxeA2, axeB2, axeC2, [act15]:fps, bsR
[act15]:fps:GFPfps marked with C-terminal GFP expressed in AX2 cellsaxeA2, axeB2, axeC2, [act15]:fps:GFP, neoR
[act15]:fr1C:GFPC-terminal GFP-tagged fr1C in AX2axeA2, axeB2, axeC2, fr1C, [pDEX-GFPC], neoR
[act15]:fszA:GFPAX3 cells expressing fszA-GFP under the control of the constitutive act15 promoteraxeA1, axeB1, axeC1, Pact15-fszA-GFP, pyr5-6-[pRG24], neoRaxe, neoR
[act15]:fszB:GFPAX3 cells expressing fzsB-GFP under the control of the constitutive act15 promoter axeA1, axeB1, axeC1, Pact15-fszB-GFP, neoR
[act15]:fszB:GFPGFP-tagged fszB in AX4axeA1, axeB1, axeC1, fszB, [pDXA-3C], neoR
[act15]:fttB(K49E):GFPexpression of fttB where the conserved lysine in the ligand-binding cleft has been mutated in wild type backgroundaxeA1, axeB1, axeC1, pyr5-6-[pRG24], [Ddp2-ORF-pyr5-6], fttB(K49E):GFP, ura+, neoR
[act15]:gbpDgbpD under the control of the act15 promoter; neomycin resistantaxeA1, axeB1, axeC1, [act15/gbpD], neoR
[act15]:gcsAgcsA overexpressed in KAX3axeA1, axeB1, axeC1, gcsA, [pExp4(+)], neoR
[act15]:GFPAX2 with GFP expressed from actin15 promoteraxeA2, axeB2, axeC2, [pDdA15gfp], neoRaxe, neoR
[act15]:GFPAX3K with GFP expressed from the actin 15 promoteraxeA1, axeB1, axeC1, [V/A15-GFP], neoRaxe, neoR
[act15]:GFPDH1 expressing GFP under the control of the act15 promoteraxeA1, axeB1, axeC1, pyr5-6-[pRG24], ura-, [pTX-GFP], neoRaxe, neoR, ura-, gfp
[act15]:GFPAX4 cells expressing GFP under the control of the constitutive act15 promoteraxeA1, axeB1, axeC1, GFP, [act15:GFP], neoR
[act15]:GFP(S65T)-racGracG overexpressor tagged with GFP at the amino terminus under the control of the act15 promoter in AX2axeA2, axeB2, axeC2, [act15]:GFP(S65T):racG, neoR
[act15]:GFP(S65T)-racG((G12V)1-122:136-201)racG-delta-123-135 overexpressor tagged with GFP at the amino terminus under the control of the act15 promoter in AX2axeA2, axeB2, axeC2, [act15]:GFP(S65T)-racG((G12V)1-122:136-201), neoR
[act15]:GFP(S65T):dng1dng1 wih GFP(S65T) fused at the N terminus nder the control ofthe act15 promoteraxeA2, axeB2, axeC2, [act15]:GFP(S65T):dng1, neoR
[act15]:GFP:abpC(1-250):mycGFP-tagged, actin-binding region of AbpC expressed in AX4axeA1, axeB1, axeC1, GFP:abpC(1-250), [pDXA-HC], neoR
[act15]:GFP:abpC(9-148)N-terminal fusion of GFP to the actin binding domain of abpC (ABP-120, ddFLN) expressed in wild typeaxeA2, axeB2, axeC2, GFP:abpC(9-148), [pDXA-GABD], neoR
[act15]:GFP:abpC(9-148)N-terminal fusion of GFP to the actin binding domain of abpC (ABP-120) expressed in AX2axeA2, axeB2, axeC2, GFP:abpC(9-148), [pDXA-GABD], neoR
[act15]:GFP:abpD(1441-1736)N-terminal fusion of GFP to a COOH-terminal abpD fragment lacking the final two residues (PT), overexpressed in wild typeaxeA2, axeB2, axeC2, GFP-abpD(1441-1736), neoR
[act15]:GFP:abpD(1441-1738)N-terminal fusion of GFP to a COOH-terminal abpD fragment containing the MAD and a short portion of the rod domain, overexpressed in wild typeaxeA2, axeB2, axeC2, GFP-abpD(1441-1738), neoR
[act15]:GFP:abpD(1441-1738N-terminal fusion of GFP to a COOH-terminal abpD fragment with a P to A mutation in residue 1737axeA2, axeB2, axeC2, GFP-abpD(1441-1738, 1737P/A), neoR
[act15]:GFP:abpEN-terminal GFP-abpE fusion overexpressed in wild type; extrachromosomal vectoraxeA2, axeB2, axeC2, GFP-abpE+[GFP-abpE-neo], neoR
[act15]:GFP:abpE(1-130)expression of a GFP-ADFH fusion, an N-terminal domain of the Dabp1 (abpE) protein, in wild typeaxeA2, axeB2, axeC2, ADFH+[ADFH-neo], neoRaxe, neoR
[act15]:GFP:abpE(413-481)expression of the C-terminal abpE SH3 domain as a GFP fusion protein in wild typeaxeA2, axeB2, axeC2, SH3+[SH3-neo], neoRaxe, neoR, increased lateral pseudpodia
[act15]:GFP:act15AX2 cells expressing GFP-actin fusion constructaxeA2, axeB2, axeC2, [pA15-gfp-actin], neoRaxe, neoR, gfp
[act15]:GFP:act15AX2 wild type cells marked with GFP under the control of the constitutive act15 promoteraxeA2, axeB2, axeC2, [act15]:GFP:act15, neoR
[act15]:GFP:aqpB(1-208GFP-tagged aqpB lacking residues 208-219 expressed in AX2axeA2, axeB2, axeC2, aqpB(1-208, 219-294), [pTX-GFP], neoR
[act15]:GFP:arpCAX2 cells expressing a GFP-Arp3 fusion construct axeA2, axeB2, axeC2, [GFP(S65T)-Arp3], neoRaxe, neoR, gfp
[act15]:GFP:aurKExpression of GFP-aurK in wild typeaxeA2, axeB2, axeC2, aurK-
[act15]:GFP:cbpGGFP-tagged cbpG overexpressed in KAX3axeA1, axeB1, axeC1, cbpG, [pEXP4(+)], neoR
[act15]:GFP:cepLcepL over expressed with N-terminal GFPin wild type AX2axeA2, axeB2, axeC2, GFP:cepL, [pBsr GFP N2], bsR
[act15]:GFP:cepL(1-1114)cepL residues 1-1114 overexpressed with N-terminal GFP in wild type AX2axeA2, axeB2, axeC2, GFP:cepL(1-1114), [pBsr GFP N2], bsR
[act15]:GFP:cepL(1-763)cepL residues 1-763 overexpressed with N-terminal GFP in wild type AX2axeA2, axeB2, axeC2, GFP:cepL(1-763), [pBsr GFP N2], bsR
[act15]:GFP:cepL(763-1114)cepL residues 763-1114 overexpressed with N-terminal GFP in wild type AX2axeA2, axeB2, axeC2, GFP:cepL(763-1114 ), [pBsr GFP N2], bsR
[act15]:GFP:copBGFP-copB expressing wild typeaxeaxeA2, axeB2, axeC2, GFP:copB [pBsr], bsR
[act15]:GFP:cpnAwild type cells expressing GFP-cpnA under the control of the act15 promoteraxe, matA1, GFP-cpnA [pTX-GFP], neoR
[act15]:GFP:crtAGFP-calreticulin in AX2axeA2, axeB2, axeC2, [GFP-calreticulin in pDEXRH], neoRwt,axe,neoR
[act15]:GFP:ctnnActnnA (vinA) overexpressed in wild typeaxeA2, axeB2, axeC2, GFP-ctnnA, neoR
[act15]:GFP:docDdocD over expressed in AX2 cellsaxeA2, axeB2, axeC2, GFP:docD, neoR
[act15]:GFP:forF(1-1087)wild type overexpressing N-terminal GFP tagged forF, lacking the diaphanous-autoregulatory domain (DAD), under the control of the act15 promoter; this renders the forF constitutively active.axeA2, axeB2, axeC2, GFP:forF, [pDGFP-MCS-Neo], neoR
[act15]:GFP:forH(1-425)GFP-tagged and C-terminally truncated drf2 (residues 1-425 expressed; FH1 and FH2 domains deleted) overexpressed in wild typeaxeA2, axeB2, axeC2, GFP:forH(1-425), neoR
[act15]:GFP:frmBGFP-tagged frmB overexpressed in KAX3axeA1, axeB1, axeC1, frmB, [pEXP4], neoR
[act15]:GFP:gefQ(172-654)wild type cells expressing GFP-gefQ lacking the first 172 amino acids and the DEP and RasGEF domainsaxeA2, axeB2, axeC2, GFP:gefQ(172-654), bsR
[act15]:GFP:gefQ(173-1298)wild type cells expressing GFP-gefQ lacking the first 172 amino acidsaxeA2, axeB2, axeC2, GFP:gefQ(173-1298), neoR
[act15]:GFP:gefQ(173-651wild type cells expressing GFP fused to the gefQ RasGEF domainaxeA2, axeB2, axeC2, GFP:gefQ(173-651, 818-1298), neoR
[act15]:GFP:gefQ(683-833)wild type cells expressing GFP fused to the gefQ DEP domainaxeA2, axeB2, axeC2, GFP:gefQ(683-833), drugR?
[act15]:GFP:gefQ(910-1298)wild type cells expressing GFP fused to the gefQ RasGEF domainaxeA2, axeB2, axeC2, GFP:gefQ(910-1298), drugR?
[act15]:GFP:gemAgemA tagged with GFP overexpressed in AX2axeA2, axeB2, axeC2, GFP:gemA, neoR
[act15]:GFP:gflBGFP-gflB over expressed in AX2axeA2, axeB2, axeC2, GFP:gflB, [bsR-cas], bsR
[act15]:GFP:golgol (golvesin) fused to GFP at the amino terminus; localizes to the endosome and contractile vacuole as untagged proteinaxeA2, axeB2, axeC2, [act15/gfp-golvesin], neoRaxe, neoR
[act15]:GFP:gol(1-558)C-terminally deleted GFP-(N)-Δ(559-579)-golvesin expressing cellsaxeA2, axeB2, axeC2GFP:gol(1-558), [pDEX], neoRaxe,neoR
[act15]:GFP:gpbBGFP-marked GpbB over-expressed in AX2-214 cellsaxeA2, axeB2, axeC2, GFP:gpbB
[act15]:GFP:gtaC(1-467:497-587)mutant overexpressing GFP fused to the N-terminus of gtaC missing the putative nuclear localization signal (NLS); gtaC can no longer localize to the nucleus.axeA2, axeB2, axeC2, [act15:GFP:gtaC(1-467:497-587)], hygR
[act15]:GFP:gtaC(229-587)mutant overexpressing GFP fused to gtaC with an N-terminal truncation (1-228) under the control of the act15 promoter.axeA2, axeB2, axeC2, [act15:GFP:gtaC(229-587)], hygR
[act15]:GFP:gtaC(281-467:497-587)mutant overexpressing GFP fused to the N-terminus of gtaC missing the nuclear localization signal (NLS) and residues 1-280axeA2, axeB2, axeC2, [act15:GFP:gtaC(281-467:497-587)]hygR
[act15]:GFP:gtaC(281-587)mutant overexpressing GFP fused to gtaC with N-terminus trucation (1-280) under the control of the act15 promoter.axeA2, axeB2, axeC2, [act15:GFP:gtaC(281-587)], hygR
[act15]:GFP:gtaC(346-467:497-587)mutant overexpressing GFP fused to the N-terminus of gtaC missing the nuclear localization signal (NLS) and residues 1-345axeA2, axeB2, axeC2, [act15:GFP:gtaC(346-467:497-587)], bsR, hygR
[act15]:GFP:gtaC(346-587)mutant overexpressing GFP fused to gtaC with N-terminus trucation (1-345) under the control of the act15 promoter.axeA2, axeB2, axeC2, [act15:GFP:gtaC(346-587), hygR
[act15]:GFP:gtaC(K469mutant overexpressing GFP fused N-terminal to gtaC with Lys and Arg residues in the NLS substituted with Ala under the control of the act15 promoter.axeA2, axeB2, axeC2, [act15:GFP:gtaC[(K469, 470, 494, 496A/R468, 471A)], hygR
[act15]:GFP:hcpAoverexpressor of N-terminal GFP-hcpA fusion under the control of the act15 promoter axeA2, axeB2, axeC2, hcpA-[GFP-hcpA], neoRaxe, neoR, slow gowth, aberrant anaphase
[act15]:GFP:hcpBN-terminal GFP-hcpB fusion under the control of the act15 promoter; overexpressoraxeA2, axeB2, axeC2, hcpB-[GFP-hcpB], neoRslow growth
[act15]:GFP:impA1impA1 under control of act15 promotor expressed in AX2axeA2, axeB2, axeC2, impA1, [pTX-GFP], neoR
[act15]:GFP:krsAkrsA fused to GFP at the N-terminus under the control of the constitutive act15 promoteraxeA2, axeB2, axeC2, [pDGFP-krsA-Neo], neoR
[act15]:GFP:leep1N-terminal GFP-marked leep1 overexpressen in AX2axeA2, axeB2, axeC2, leep1, [pDM317], neoR
[act15]:GFP:limEexpression of limE fused at the N-terminus to GFP, in wild type cellsaxeA2, axeB2, axeC2, limE [pDEXRH-limE], neoR
[act15]:GFP:lis1GFP-marked lis1 under control of act5 promotor in AX2axeA2, axeB2, axeC2, lis1, [pTX-GFP], neoR
[act15]:GFP:lmnBlmnB overexpressed and labeled with N-terminal GFP; unstable, disappeared after several passagesaxeA2, axeB2, axeC2, GFP:lmnB, [plS191], bsR
[act15]:GFP:mhcA(T1823D/T1833D/T2029D)/AX33xAsp mutant mhcA, which mimicks the fully phosphorylated state, in AX3axeA1, axeB1, axeC1, [pREP], GFP:mhcA(T1823D/T1833D/T2029D), [pDRHyg], hygR
< Previous 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 Next >
Home| Contact dictyBase| SOPs| Site Map  Supported by NIH (NIGMS and NHGRI)